High-risk human papillomaviruses (HPVs), especially HPV-16, play a primary role in the pathogenesis of cervical cancer. HPV-16 encodes the E5, E6 and E7 oncoproteins. Although the biological functions of E5 are poorly understood, recent studies indicate that its expression correlates with papillomavirus oncogenicity. In this study we demonstrate that the HPV-16 E5 oncoprotein increases plasma membrane expression of caveolin-1, which is a constituent of lipid rafts and regulator of cell signaling, and that this phenotype is mediated by the C-terminal 10 amino acids of E5. Moreover, E5 (but not mutant E5) induces a 23-to 40-fold increase in the lipid raft component, ganglioside GM1, on the cell surface and mediates a dramatic increase in caveolin-1/GM1 association. Since gangliosides strongly inhibit cytotoxic T lymphocytes, block immune synapse formation and are expressed at high levels on the surface of many tumor cells, our results suggest a potential mechanism for immune evasion by the papillomaviruses. Additionally, surface gangliosides are known to enhance proliferative signaling by the epidermal growth factor (EGF) receptor, providing a possible mechanistic basis for observations that EGF signaling is enhanced in E5-expressing cells. Finally, the upregulation of caveolin-1 and ganglioside GM1 at the plasma membrane of E5-expressing cervical cells provides potential new therapeutic targets and diagnostic markers for high-risk HPV infections.
Introduction
It is well established that high-risk human papillomaviruses (HPVs) are the primary causative agent of cervical cancer (Walboomers et al., 1999) . In particular, HPV type 16 (HPV-16) is responsible for more than 50% of cervical malignancies worldwide (Clifford et al., 2003) . The oncogenic potential of HPV-16 has largely been attributed to its E6 and E7 gene products, which interfere with the function of numerous regulatory proteins of the host cell to promote proliferation, immortalization and malignant transformation in vitro and in vivo (Fehrmann and Laimins, 2003) . The HPV-16 E5 oncoprotein (16E5) exhibits weak transforming activity in vitro (Suprynowicz et al., 2006) ; however epidemiological and experimental evidence increasingly suggests that 16E5 functions during early stages of HPV-16 infection to increase the probability of subsequent malignant progression in vivo.
A study of HPV infection and cervical cancer finds that carcinogenic HPV types encode an E5 protein, whereas most low-risk HPV types lack an E5 gene or a translation start codon for E5 (Schiffman et al., 2005) . Additionally, targeted expression of 16E5 in basal epithelial cells of transgenic mice induces skin tumors at a high frequency (Genther-Williams et al., 2005) , and estrogen-treated transgenic mice that express HPV-16 E5, E6 and E7 develop a higher number of cervical cancers than transgenic mice that express E6 and E7 without E5 (Riley et al., 2003) .
Unlike the well-characterized HPV-16 E6 and E7 oncoproteins, the biological functions of 16E5 remain largely unknown (Suprynowicz et al., 2006) . The only cellular proteins known to bind 16E5 are the 16 kDa pore-forming c subunit of the vacuolar H þ -ATPase (V-ATPase) (Conrad et al., 1993) and heavy chain of the major histocompatibility class I complex (HLA I) (Ashrafi et al., 2006) . The association of 16E5 with the V-ATPase c subunit is thought to interfere with endosome acidification and enhance ligand-dependent activation of the epidermal growth factor (EGF) receptor (Rodriguez et al., 2000) . The interaction of 16E5 with the HLA I heavy chain retains HLA I in the endoplasmic reticulum (ER) and Golgi apparatus and reduces its expression on the cell surface by 50% (Ashrafi et al., 2006) .
Lipid rafts are membrane microdomains characterized by increased levels of cholesterol and sphingolipids that exhibit reduced fluidity and resistance to detergent extraction (Brown and London, 1998; Chamberlain, 2004) . These structures are enriched in lipid-modified proteins and serve as platforms for many types of receptor-mediated signaling (Brown and London, 1998) . A subset of lipid rafts additionally contains the integral membrane protein caveolin-1, which induces membrane invaginations (caveolae) as a result of its oligomerization and association with the actin cytoskeleton .
Despite the progress that has been made in understanding biological activities of HPV-16 oncoproteins, no profound HPV-16-dependent alteration of the cell surface has been identified. In the present study, we show that levels of the lipid raft components caveolin-1 and ganglioside GM1 are dramatically increased at the plasma membrane of human ectocervical cells (HECs) that express HPV-16 E5, E6 and E7, relative to E6/E7-expressing cells that do not express 16E5 or that express a C-terminal deletion mutant of 16E5. The well-documented association of caveolin-1 and ganglioside GM1 that occurs in lipid rafts (Parton, 1994; Fra et al., 1995) is highly elevated in 16E5-expressing cells, suggesting that 16E5-dependent increases in lipid raft components at the plasma membrane are indicative of organized raft structures.
Results

16E5 localizes to the detergent-resistant membrane fraction of HECs
To study biological activities of 16E5 in its natural host cell in the presence of other HPV-16 gene products that are present during early stages of infection in vivo, primary HECs were immortalized by transduction with the HPV-16 E6 and E7 genes (Baege et al., 2002) . These parental cells were used to generate stable cell lines that express codon-optimized 16E5 (Disbrow et al., 2003) or a 10 amino acid C-terminal deletion mutant of codonoptimized 16E5 that is defective for numerous biological activities, including alkalinization of the Golgi apparatus and enhancement of ligand-dependent EGF receptor activation (Rodriguez et al., 2000) . 16E5 genes were engineered to express the 6 amino acid-AU1 epitope tag at their N terminus, which allows immunological detection without affecting protein function (Disbrow et al., 2003) . As shown by immunoprecipitation and western blotting, the fulllength 16E5 protein and 16E5(À10) mutant are expressed at equivalent levels in the HEC lines (Figure 1a) . In contrast to transient overexpression of the codonoptimized 16E5 gene in primary keratinocytes (Disbrow et al., 2003) , the stable cell lines employed in our study show no evidence of cytotoxicity, which most likely reflects expression of a single or limited number of retroviral-transduced 16E5 genes. Although the level of codon-optimized 16E5 expression is approximately sixfold greater than the wild-type (wt) 16E5 gene (Disbrow et al., 2003) , it is expected to be less than occurs during HPV infection in vivo, where early viral genes (including E5) are expressed from 50 to 100 episomal copies of the viral genome (Suprynowicz et al., 2006) .
The insolubility of lipid rafts in Triton X-100 at 41C has been employed widely for their purification, and has served as a criterion for the localization of proteins to lipid rafts (Brown and London, 1998; Chamberlain, 2004) . Both 16E5 and 16E5(À10) are insoluble in Triton X-100 at 41C, but are solubilized by a mixture of detergents (sodium dodecyl sulfate (SDS), Nonidet P-40 and sodium deoxycholate) (Figure 1b) . In contrast, the transferrin receptor (Tf-R) is not present in lipid rafts (Chamberlain, 2004) , and is solubilized equally well by Triton X-100 and the detergent mixture (Figure 1b) . Therefore, detergent solubility properties suggest that 16E5 is localized in lipid rafts.
16E5 is associated with immature lipid rafts in the ER
To establish the subcellular distribution of 16E5 in HECs, immunofluorescence microscopy was performed using mouse antibodies that recognize the AU1 epitope tag and rabbit antibodies that label specific cellular organelles. Both 16E5 and 16E5(À10) co-localize with calnexin (Figure 2a) , an integral membrane protein of the ER. In contrast, neither 16E5 protein co-localizes with Golgi matrix protein GM-130 (GM-130), a marker for the Golgi apparatus (Figure 2b ), or fluorescent EGF, a marker for endosomes (Figure 2c) .
Cholesterol, an important structural component of lipid rafts, is synthesized in the ER; however, sphingolipid synthesis and head group modification mainly occur in the Golgi apparatus (van Meer, 1989) . Therefore, in the membrane biosynthetic pathway, fully assembled lipid rafts are first present in Golgi membranes (Brown and London, 1998) . Consistent with our localization of wt and mutant 16E5 proteins to the ER, fractionation of detergent-resistant membranes on HPV-16 E5 upregulates plasma membrane raft components FA Suprynowicz et al sucrose density gradients ( Figure 3) shows that membranes containing 16E5 and 16E5(À10) are distinct from fully assembled lipid rafts containing caveolin-1 (caveolar rafts; Sotgia et al., 2002) or flotillin-2 (noncaveolar rafts; Stuermer et al., 2001) . Therefore, 16E5 is associated with immature lipid rafts in the ER.
16E5 causes a redistribution of caveolin-1 to the plasma membrane To investigate whether the association of 16E5 with lipid rafts in the ER alters the level of lipid raft components at the plasma membrane, we localized caveolin-1, a protein component of lipid rafts , in our HEC lines by immunofluorescence microscopy. As shown in Figure 4a , caveolin-1 is not detectable on the outside of intact (unfixed) cells, consistent with a membrane topology that includes cytoplasmic exposure of both the N-and C-termini . During the course of these experiments we found that paraformaldehyde fixation of cells, without detergent permeabilization, allows preferential labeling of caveolin-1 at the cytoplasmic surface of the plasma membrane relative to caveolin-1 that is associated with intracellular membranes. Control (pLXSN) HECs labeled in this manner exhibit a low level of caveolin-1 staining; however strong plasma membrane staining is observed in 16E5-expressing cells ( Figure 4a ). Frequently, the most intense labeling in these cells is restricted to one or two regions of the plasma membrane ( Figure 4a ). Importantly, cells expressing 16E5(À10) exhibit weak anti-caveolin-1 immunofluorescence that is indistinguishable from control cells ( Figure 4a ). The 16E5-dependent increase in caveolin-1 at the plasma membrane was quantitatively measured using flow cytometry of fixed cells without detergent permeabilization. As shown (Figure 4b ), the mean level of caveolin-1 labeling in 16E5-expressing cells is sixfold higher than cells expressing 16E5(À10), and 3.9-fold higher than pLXSN cells. In contrast, all three cell lines exhibit strong anticaveolin-1 labeling of the plasma membrane, cytoplasm and perinuclear region if permeabilized with saponin after fixation (Figure 4a ), indicating that total caveolin-1 in 16E5-expressing cells is only 1.1-fold higher than cells expressing 16E5(À10) and 1.6-fold higher than pLXSN cells (Figure 4b ). These measurements are in agreement with anti-caveolin-1 immunoblots of whole cell lysates, which show that 16E5 slightly increases levels of the caveolin-1a and 1b isoforms (Figure 5a ). The observation that paraformaldehyde fixation partially permeabilizes cells has been noted by others and is supported by immunofluorescence labeling of the Golgi apparatus matrix protein, GM-130. GM-130 is not labeled in intact (unfixed) HECs, labels weakly in To confirm our finding that 16E5 significantly increases plasma membrane-associated caveolin-1, total cellular membranes were fractionated on sucrose density gradients that separate plasma membrane from organelle membranes (Denker et al., 1996) . As shown (Figure 5b ), the plasma membrane-associated proteins yes and Tf-R are primarily present in gradient fractions 1-4, while markers for membranes of the Golgi apparatus (b-COP) and ER (calnexin) are restricted to fractions 9-12. Caveolin-1 predominantly co-fractionates with the plasma membrane in control (pLXSN) HECs, although a small amount is present in other gradient fractions (Figure 5b) . A similar level of caveolin-1 is associated with the plasma membrane in cells that express 16E5(À10), however caveolin-1 is elevated in organelle membranes (Figure 5b ). Although organelle gradient fractions contain both ER and Golgi markers, caveolin-1 is present in the Golgi apparatus but not in the ER (Thomsen et al., 2002) . In contrast, caveolin-1 is strongly increased in the plasma membrane and Golgi membranes of 16E5-expressing cells (Figure 5b ). Therefore, both immunofluorescence measurements and sucrose density gradients demonstrate that 16E5 induces a four-to sixfold redistribution of caveolin-1 to the plasma membrane of HECs, and that the C-terminal 10 amino acids of 16E5 are critical for this activity.
16E5 dramatically increases ganglioside GM1 on the cell surface Ganglioside GM1 is a key structural component of lipid rafts, including rafts that contain caveolin-1 (Parton, 1994; Fra et al., 1995) . The B subunit of cholera toxin (CT-B) selectively binds to ganglioside GM1 and has been used widely to localize lipid rafts in cells (Parton, 1994) . To determine whether 16E5 causes a generalized redistribution of lipid raft components to the plasma membrane, rather than a specific redistribution of caveolin-1, we labeled unfixed HECs with a fluorescent 
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FA Suprynowicz et al conjugate of CT-B to measure levels of ganglioside GM1 on the extracellular surface of the plasma membrane. Cells that express 16E5 label strongly with fluorescent CT-B, indicating that a high level of ganglioside GM1 is exposed on the surface, while 16E5(À10)-expressing cells and pLXSN cells label relatively weakly (Figure 6a ). In contrast, all three cell lines label intensely when fluorescent CT-B is applied after fixation and permeabilization with saponin; indicating that the overall amount of ganglioside GM1 per cell is similar (Figure 6a ). Madin Darby canine kidney cells, which do not contain ganglioside GM1 (Hansson et al., 1986) , do not label with fluorescent CT-B (Figure 6a ). These results were quantified using flow cytometry. As shown (Figure 6b ), the mean intensity of CT-B labeling without detergent permeabilization is 23-fold higher in 16E5-expressing cells than pLXSN control cells (40-fold higher in two other experiments); while 16E5(À10)-expressing cells label only 3.5-fold more intensely than the controls. Alternatively, fluorescent CT-B labeling of detergent-permeabilized HECs is only 2.4-to 3.0-fold higher in 16E5-and 16E5(À10)-expressing cells than in pLXSN cells (Figure 6b ). Our results demonstrate that 16E5 induces a dramatic redistribution of multiple lipid raft components (caveolin-1 and ganglioside GM1) to the plasma membrane in HECs, and that the deletion of 10 amino acids from the C terminus of 16E5 abrogates its ability to induce this phenotype. It is well documented that ganglioside GM1 physically associates with caveolin-1 in caveolar lipid rafts (Parton, 1994; Fra et al., 1995) . To determine whether the 16E5-induced redistribution of caveolin-1 and ganglioside GM1 to the plasma membrane is indicative of an increase in organized caveolar raft structures, ganglioside GM1 was isolated from whole cell lysates of HECs using biotinylated CT-B and streptavidin-coated agarose beads, and SDS eluates of the beads were probed for associated caveolin-1 by western blotting. While no caveolin-1 is detectable in ganglioside GM1 eluates from 16E5(À10) and pLXSN cells, 41% of the total caveolin-1 in 16E5-expressing cells is bound to ganglioside GM1 (Figure 6c ).
16E5-induced redistribution of ganglioside GM1 is not mediated by disruption of the cytoskeleton or lipid rafts
Cholesterol is essential for the integrity of lipid rafts, and depletion of cholesterol from the plasma membrane with methyl-b-cyclodextrin disrupts lipid raft organization (Hao et al., 2004) . Additionally, microfilament depolymerization can disrupt lipid rafts (Bacia et al., 2004) . The latter finding is of particular interest, since it has been reported that 16E5 induces complete disassembly of microfilaments in mouse fibroblasts (Thomsen et al., 2000) . However, fluorescent labeling of filamentous actin in our HEC lines clearly shows that neither 16E5 nor 16E5(À10) perturbs the actin cytoskeleton (Figure 7a) . Treatment of HECs with latrunculin A, a potent, membrane-permeable anti-microfilament agent, does completely depolymerize microfilaments in all three HEC lines (Figure 7a ). Since microtubules also influence the distribution of caveolin-1 between the plasma membrane and Golgi apparatus in vivo (Mundy et al., 2002) , we also determined that 16E5 does not disrupt microtubules in HECs (Figure 7a) .
To demonstrate that 16E5 does not appear to increase levels of ganglioside GM1 at the plasma membrane by dispersing lipid raft components, we measured ganglioside GM1 on the surface of pLXSN HECs following treatment with methyl-b-cyclodextrin and latrunculin A to disrupt lipid rafts by depleting cholesterol and depolymerizing microfilaments. As shown (Figure 7b ), this treatment increases plasma membrane-associated ganglioside GM1 only slightly compared to the increase induced by 16E5. HPV-16 E5 upregulates plasma membrane raft components FA Suprynowicz et al Discussion HPV infections usually are eliminated after several months by a cell-mediated host immune response involving cytotoxic T-lymphocytes (CTLs) (Frazer, 1996) . Persistent high-risk HPV infections, which avoid immune detection, pose significant risk for the development of cancer (O'Brien and Campo, 2002) . A mechanism has been proposed for immune evasion by HPV-infected cells, based on the finding that 16E5 binds and sequesters the HLA I heavy chain in the ER and Golgi apparatus of HaCaT cells, causing a 50% reduction in surface expression of the HLA I molecules HLA-A and HLA-B (Ashrafi et al., 2006) . Nevertheless, in the absence of functional studies, the extent to which immune surveillance is suppressed by a 50% downregulation of surface HLA I remains uncertain.
There is, however, an alternative means by which 16E5 could mediate immune evasion. It is well established that the cytotoxic activity of CTLs and natural killer (NK) cells requires an area of contact with the target cell termed the immune synapse (Davis and Dustin, 2004) . In both CTLs and NK cells, the immune synapse is formed by a dynamic process that involves the recruitment of immune receptors and adhesion molecules, mobilization of lipid rafts and remodeling of the cytoskeleton (Grakoui et al., 1999; Vyas et al., 2002) . Importantly, a fourfold increase in ganglioside GM1 on the surface of leukemic cells following treatment with imatinib mesylate strongly inhibits immune synapse formation with NK cells in vitro by preventing the rearrangement of lipid raft-associated antigens and receptors in both the target and NK cells (Cebo et al., 2006) . Given the similarities of immune synapse structure and dynamics in NK cells and CTLs, our finding that ganglioside GM1 is elevated 23-to 40-fold on the surface of 16E5-expressing HECs suggests that HPV-16-infected cells may avoid cell-mediated immune detection in vivo due to an impaired ability to form immune synapses. In addition, increased ganglioside GM1 on the surface of 16E5-expressing cells may exert immunosuppressive activity if it is released into the surrounding milieu. Many tumor cells overexpress gangliosides that are released into the extracellular microenvironment and inhibit the cellular immune response at multiple steps, including dendritic cell function (Shurin et al., 2001) and CTL proliferation (McKallip et al., 1999) .
If functional studies confirm a link between the 16E5-dependent increase in surface ganglioside GM1 and immunosuppression, selective inhibition of either 16E5 expression or enzymes involved in ganglioside GM1 synthesis may allow the host immune system to eliminate HPV-16 infections before they progress to cancer. Additionally, the extent to which ganglioside GM1 is overexpressed on the surface of 16E5-expressing cells and ease of detection with fluorescent CTB may allow rapid identification of early stage HPV-16 infections in Pap smears and other clinical specimens. To date, no HPV-dependent alterations of the cell surface have been reported which are of sufficient magnitude for diagnostic purposes.
A second major cancer-promoting activity that has been proposed for 16E5 is enhanced EGF-dependent proliferation that would expand the size of HPVinfected populations (Rodriguez et al., 2000) . Although the focus of our study was not growth factor receptors, increased ganglioside GM1 has been shown to enhance proliferative signaling by the EGF receptor at low concentrations of EGF (Nishio et al., 2005) , suggesting that 16E5 may enhance immune evasion and cell proliferation via a common mechanism.
Our results indicate that 16E5 induces a redistribution of protein (caveolin-1) and glycosphingolipid (ganglioside GM1) components of lipid rafts to the plasma membrane, while other work has shown that 16E5 increases plasma membrane-associated cholesterol (Bravo et al., 2005) ; another major constituent of lipid rafts. These molecules appear to be assembled into organized raft structures, since we demonstrate a large increase in the association of caveolin-1 and ganglioside GM1 specifically in 16E5-expressing cells. While the HPV-16 E5 upregulates plasma membrane raft components FA Suprynowicz et al mechanism underlying this new 16E5-dependent phenotype will require further investigation, it is clear that deleting 10 amino acids from the C terminus of 16E5 abrogates its ability to induce the phenotype. Interestingly, this domain is critical for inhibiting the acidification of endosomes . It is possible that interference with vesicle acidification (and consequent vesicle fusion/trafficking) might alter trafficking of caveolin-1 and ganglioside GM1. To help identify cellular targets that mediate the bioactivity of 16E5, we plan to screen HECs for proteins that differentially interact with 16E5 but not with 16E5(À10).
In the present study, we expressed wt and mutant 16E5 proteins in primary HECs that were immortalized with the HPV-16 E6 and E7 genes. This allowed us to study the biological activities of 16E5 in its natural host cell in the presence of two other HPV-16 early gene products. In the future, it will be important to determine whether co-expression of the E6 and E7 proteins is necessary for 16E5-dependent changes in the distribution of lipid raft components by transducing primary epithelial cells with 16E5. It will also be important to compare the expression of 16E5 in HPV lesions in vivo (where there are hundreds of episomal genome copies) to our stable cervical cell lines (where there are a limited number of integrated 16E5 genes). The development of sensitive and specific antibodies for the native 16E5 protein will permit such comparisons.
Materials and methods
Cells and viruses
Retroviruses encoding HPV-16 E6 and E7 in pBabePuro, or codon-optimized 16E5 or 16E5(À10) in pLXSN, were generated as described (Suprynowicz et al., 2005; Disbrow et al., 2003 Disbrow et al., , 2005 . Primary HECs were derived from fresh cervical tissue after hysterectomy for benign uterine disease and cultured according to Baege et al. (2002) . Cells were immortalized by infection with retroviruses encoding HPV-16 E6 and E7 and selection in the presence of puromycin (0.5 mg/ml). Stable cell lines were generated from immortalized HECs by infection with retroviruses encoding 16E5, 16E5(À10) or the pLXSN empty vector and selection in the presence of geneticin G418 (100 mg/ml).
Detergent extraction and cell lysis
HECs were extracted with Triton X-100 buffer (Skibbens et al., 1989) for 20 min at 41C with gentle rocking. After removing the extraction buffer, detergent-resistant membranes were scraped into modified radioimmunoprecipitation assay (RIPA) buffer (Suprynowicz et al., 2005) . Total cellular membranes were prepared by extracting HECs with modified RIPA buffer. Cell lysates were prepared as described (Suprynowicz et al., 2005) .
Sucrose density gradients
Total cellular membranes were fractioned on sucrose density gradients according to Denker et al. (1996) . Detergentresistant membranes were fractionated using a modification of procedures described by Sotgia et al. (2002) . Supplementary Information is available at Oncogene's web site.
Immunoprecipitation and immunoblotting
Methods for detecting 16E5 proteins have been published (Suprynowicz et al., 2005) . Immunoblots were also labeled with mouse monoclonal antibodies recognizing the Tf-R, caveolin-1, yes, flotillin-2 (BD Biosciences, San Jose, CA, USA) and b-actin (Sigma, St Louis, MO, USA), or rabbit polyclonal antibodies recognizing b-COP (Affinity Bioreagents, Golden, CO, USA) and calnexin (Santa Cruz Biotechnologies, Santa Cruz, CA, USA). Ganglioside GM1 was precipitated from RIPA lysates using 4 mg of biotinylated CT-B (Invitrogen, Carlsbad, CA, USA) and 50 ml of 50% (v/v) streptavidin-agarose suspension (Pierce, Rockford, IL, USA) per milligram of cell protein.
Immunofluorescence microscopy Cells grown on 22 Â 22 mm glass coverslips were labeled for anti-AU1 immunofluorescence microscopy as described (Suprynowicz et al., 2005) . Additional primary antibodies employed were: anti-calnexin and anti-caveolin-1 rabbit polyclonals, anti-b tubulin mouse monoclonal (Santa Cruz) and anti-GM-130 rabbit polyclonal (Calbiochem, La Jolla, CA, USA). Nonimmunological labeling procedures are available as Supplementary Information at Oncogene's web site.
Flow cytometry
Details of flow cytometry procedures are available as Supplementary Information at Oncogene's web site.
